Ausgabe 18/2014
Inhalt (10 Artikel)
Acknowledgement to Referees
The Biology and Clinical Development of MEK Inhibitors for Cancer
Jason J. Luke, Patrick A. Ott, Geoffrey I. Shapiro
Intensive Intervention Can Lead to a Treatment Holiday from Biological DMARDs in Patients with Rheumatoid Arthritis
Yoshiya Tanaka, Shintaro Hirata
Combining a GLP-1 Receptor Agonist and Basal Insulin: Study Evidence and Practical Considerations
Nicholas W. Carris, James R. Taylor, John G. Gums
Rifaximin: A Review of Its Use in Reducing Recurrence of Overt Hepatic Encephalopathy Episodes
Lesley J. Scott
Liraglutide: A Review of Its Use in Adult Patients with Type 2 Diabetes Mellitus
Lesley J. Scott
Pramipexole Extended-Release: A Review of Its Use in Patients with Parkinson’s Disease
James E. Frampton
Dapagliflozin: A Review of Its Use in Patients with Type 2 Diabetes
Greg L. Plosker
Erratum to: New Directions for Rabbit Antithymocyte Globulin (Thymoglobulin®) in Solid Organ Transplants, Stem Cell Transplants and Autoimmunity
Mohamad Mohty, Andrea Bacigalupo, Faouzi Saliba, Andreas Zuckermann, Emmanuel Morelon, Yvon Lebranchu